Hotline 24/7: 0909384389

Share links:

First-in-human results of Captis embolic protection device presented at EuroPCR 2022

Ngày 06/06/2022 06:46 | Lượt xem: 495

Filterlex Medical has announced results from a first-in-human (FIH) study demonstrating the safety, feasibility, and performance of the Captis device, a full-body embolic protection device that reduces risk of stroke and other complications during left-heart procedures.

Study data by presented at EuroPCR 2022 (17–20 May, Paris, France) by Ran Kornowski (Rabin Medical Center, Tel Aviv, Israel). The trial was a prospective, single-arm study involving 20 patients who underwent a successful transcatheter aortic valve implantation (TAVI) procedure while using the Captis embolic protection device.

Key outcomes from the trial included 100% technical device performance success, with the Captis device having been successfully deployed and retrieved in all patients, and the TAVI procedure performed with no interference.

Kornowski also reported that there were no device related complications, and no patients experienced cerebrovascular events (objectively examined by an independent neurologist).

The Captis device is securely positioned in the aorta, protecting its surface, while facilitating a seamless TAVI procedure, without additional arterial access, Filterlex Medical detailed in a press release.

Haim Danenberg (Wolfson Medical Center, Holon, Israel) and the study’s principal investigator, said: “Safe and effective brain protection in percutaneous heart procedures is a true unmet need—I am very impressed with the promising Captis technology. Filterlex has developed an innovative solution that protects TAVI patients’ brain and kidneys.”

Kornowski added: “I am excited about the successful results in the FIH study and look forward to being part of future Captis research.”

Source CardiovascularNews

Duc Tin CLinic

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

CUSTOMER REVIEWS

• I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

  I sincerely thank you !. Tel: 0938303275

• Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

  Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

• As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

• The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

• I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.

Search

News

Customer support